Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

News Conference News TCT 2025

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

Michael O'Riordan

October 26, 2025

News Conference News EAS 2023

Newest Resorbable Magnesium Scaffold Shows Promise in BIOMAG-1

Michael O'Riordan

May 25, 2023

News Industry News

TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism

September 13, 2022

News Conference News EuroPCR 2021

FUTURE II: A Good ‘First Step’ for Thinner-Strut Bioresorbable Scaffold

Michael O'Riordan

May 19, 2021

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Conference News ESC 2018

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

Michael O'Riordan

August 29, 2018

Presentation CIT 2018

A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Vascular Scaffold in Patients with Coronary Artery Disease (FUTURE-I): Two-Year Clinical and Imaging Outcomes

Presenter: Bo Xu

March 23, 2018

News Daily News

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

Michael O'Riordan

October 11, 2017

Presentation JIM 2017

“Clinical Outcome and My Experience of MeRes 100 BioResorbable Scaffold”

Presenter: Sasko Kedev

February 10, 2017

News Features

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Shelley Wood

December 30, 2016

Presentation TCT 2016

FUTURE-I: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Bo Xu

October 31, 2016

Presentation TCT 2016

FORTITUDE: Nine-Month Clinical, Angiographic, and OCT Results With an Amorphous PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Antonio Colombo

October 31, 2016

Presentation TCT 2016

MeRes-1: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Ashok Seth

October 31, 2016

Presentation JIM 2016

Imaging modalities to guide bio-absorbable scaffolds

Presenter: Corrado Tamburino

February 11, 2016

News Daily News

Bioresorbable Scaffolds May Have Role in Spontaneous Coronary Artery Dissections

Todd Neale

December 30, 2015

News Daily News

一项小规模OCT研究发现，对生物吸收支架的长期反应是有益的

December 04, 2014

News Daily News

Un Pequeño Estudio OCT Sugiere una Respuesta Favorable a Largo Plazo al Andamiaje Bioabsorbible

December 04, 2014

News Daily News

Small OCT Study Suggests Favorable Long-term Response to Bioresorbable Scaffold

December 04, 2014

News Daily News

Un Estudio OCT Sugiere que ‘Tapar’ la Placa es Más Seguro con BRS que con SMD

November 06, 2014

News Daily News

OCT研究表明，采用BRS时的斑块“帽子形成”比BMS更安全

November 06, 2014

Advertisement

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

Newest Resorbable Magnesium Scaffold Shows Promise in BIOMAG-1

TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism

FUTURE II: A Good ‘First Step’ for Thinner-Strut Bioresorbable Scaffold

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Vascular Scaffold in Patients with Coronary Artery Disease (FUTURE-I): Two-Year Clinical and Imaging Outcomes

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

“Clinical Outcome and My Experience of MeRes 100 BioResorbable Scaffold”

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

FUTURE-I: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

FORTITUDE: Nine-Month Clinical, Angiographic, and OCT Results With an Amorphous PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

MeRes-1: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

Imaging modalities to guide bio-absorbable scaffolds

Bioresorbable Scaffolds May Have Role in Spontaneous Coronary Artery Dissections

一项小规模OCT研究发现，对生物吸收支架的长期反应是有益的

Un Pequeño Estudio OCT Sugiere una Respuesta Favorable a Largo Plazo al Andamiaje Bioabsorbible

Small OCT Study Suggests Favorable Long-term Response to Bioresorbable Scaffold

Un Estudio OCT Sugiere que ‘Tapar’ la Placa es Más Seguro con BRS que con SMD

OCT研究表明，采用BRS时的斑块“帽子形成”比BMS更安全

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content